Format

Send to

Choose Destination
See comment in PubMed Commons below
Pathology. 2013 Oct;45(6):567-73. doi: 10.1097/PAT.0b013e3283650bab.

Epithelial-mesenchymal transition phenotype is associated with patient survival in small intestinal adenocarcinoma.

Author information

1
*Departments of Pathology, Yeungnam University College of Medicine, Daegu †Chonbuk National University Medical School, Jeonju ‡Inje University Sanggye Paik Hospital, Seoul §Kyungpook National University School of Medicine, Daegu ||Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea ¶currently Department of Pathology, Daegu Fatima Hospital, Daegu, South Korea.

Abstract

AIMS:

We investigated the clinical significance of epithelial-mesenchymal transition (EMT) phenotype in 184 small intestinal adenocarcinomas (SIACs) based on the expression pattern of EMT-related proteins in cancer cells.

METHODS:

Immunohistochemistry for epithelial (E-cadherin) and mesenchymal (vimentin and fibronectin) markers were performed and cases of SIAC were classified into four subtypes of EMT: complete type (E-cadherin-, vimentin+ and/or fibronectin+), wild type (E-cadherin+, vimentin-, fibronectin-), incomplete 1 type (hybrid type; E-cadherin+, vimentin+ and/or fibronectin+), and incomplete 2 type (null type; E-cadherin-, vimentin-, fibronectin-).

RESULTS:

We identified 19 (10.3%) cases of complete EMT type, 86 (46.7%) cases of wild type and 79 (43%) cases of incomplete EMT type [hybrid type, 22 (12%) cases; null type, 57 (31%) cases]. Complete EMT phenotype showed a significant association with undifferentiated histology (p<0.001). Overall survival of SIAC patients with complete EMT phenotype was significantly shorter than those of patients with incomplete (p=0.001) and wild (p<0.001) types. In multivariate analysis, complete EMT phenotype was an independent prognostic factor in SIAC patients (hazard ratio 2.3; 95% confidence interval 1.15-4.6; p=0.019).

CONCLUSION:

Complete EMT phenotype stratifies a specific group representing a poor clinical outcome in patients with SIAC.

PMID:
24018801
DOI:
10.1097/PAT.0b013e3283650bab
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center